Monthly Archives: August 2014

Oxford University Hospitals commits to AllTrials

Oxford University Hospitals NHS Trust has pledged its support for increased transparency in medical research by supporting the AllTrials campaign.

Oxford University Hospitals has signed the campaign pledge and commits to the principles that all clinical trials should be registered and the results should be published.

The Trust supports a growing portfolio of more than 1,300 patient-centred […]

22nd August 2014|

AllTrials writes to the members of the EMA Management Board

The EU medicines body has been discussing the final wording of its draft policy on sharing data from clinical trials. We and hundreds of you have been urging them not to take a backwards step on transparency. The Management Board of the European Medicines Agency (EMA) sets policies for the EMA and delayed agreeing the […]

19th August 2014|

Barriers to clinical trials in India

In an article on The New Indian Express, members of the Indian Society for Clinical Research (ISCR) say that recent regulations are to blame for a drop in the number of clinical trials being conducted in India. The Indian government introduced new regulations following a Supreme Court ruling in 2013, one of which requires trial […]

18th August 2014|

Most discontinued trials remain unpublished

A new research paper in JAMA looking at 1017 clinical trials has found that most trials stopped before the planned end remain unpublished, and overall 56% never published results. An international research group was given access to the records of all the clinical trials approved by six ethics committees in Switzerland, Germany and Canada between […]

14th August 2014|

Should the EMA be allowed to censor independent analysis of side effect data?

The European body which oversees the collection of information on side effects of drugs wants to have the right to censor reporting of independent analysis of this information if it doesn’t agree with the analysis.

The European Medicines Agency oversees the EudraVigilance database where reports of side effects from approved drugs in Europe are recorded. Some […]

6th August 2014|

Panel: Make statins trial data available

The side effects of statins would be clearer with more data. This was illustrated very recently by the report of an independent panel which looked at two papers published by The BMJ that contained errors. Click here to read the background on the panel. The panel called for data from clinical trials on statins to […]

4th August 2014|